Buprenorphine And Naloxone Tablet
Product Images NDC 0121-2036

5 FDA label images from Pai Holdings, Llc Dba Pai Pharma · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 0121-2036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine Hydrochloride)

Chemical Structure (Buprenorphine Hydrochloride)
Chemical structure diagram of buprenorphine hydrochloride, showing its molecular framework with hydroxyl, methoxy, and cyclopropyl groups and the associated hydrochloride (HCl) component.*
FDA Label Image

Chemical Structure (Naloxone Hydrochloride Dihydrate)

Chemical Structure (Naloxone Hydrochloride Dihydrate)
Chemical structure of buprenorphine hydrochloride dihydrate, showing the molecular skeleton with hydroxyl, ketone, and amine functional groups along with hydrochloride and two water molecules.*
FDA Label Image

Figure 3 (Bupnaltabs 3)

Figure 3 (Bupnaltabs 3)
An instructional diagram showing placement of a tablet under the tongue inside the mouth. The image depicts a hand holding a tablet and positioning it beneath the tongue, illustrating sublingual administration of medication.*
FDA Label Image

2 mg/0.5 mg Sublingual Tablet 30-count Bottle Label (Bupnaltabs 4)

2 mg/0.5 mg Sublingual Tablet 30-count Bottle Label (Bupnaltabs 4)
Label for Buprenorphine and Naloxone Sublingual Tablets 2 mg / 0.5 mg, containing 30 tablets. The label includes the NDC 0121-1018-30, manufacturer Ethypharm S.A., and distributor PAI Pharma, Greenville, SC. It provides dosage form as sublingual tablets and storage instructions. Barcode and regulatory symbols are visible.*
FDA Label Image

8 mg/2 mg Sublingual Tablet 30-count Bottle Label (Bupnaltabs 5)

8 mg/2 mg Sublingual Tablet 30-count Bottle Label (Bupnaltabs 5)
Label for Buprenorphine and Naloxone Sublingual Tablets, 8 mg / 2 mg strength, containing 30 tablets. The label lists the active ingredients as buprenorphine hydrochloride and naloxone hydrochloride. It includes storage instructions, manufacturer information (Ethypharm S.A., France), and distributor details (PAI Pharma, Greenville, SC). A barcode and an NDC (0121-2036-30) are present. The product is marked Rx only and includes a pharmacist instruction for dispensing the Medication Guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.